SEARCH

SEARCH BY CITATION

References

  • 1
    Medicines Control Agency. Proposals for Supplementary Prescribing and Pharmacists and Proposed Amendments to the Prescription Only Medicines (Human Use) Order 1997. Consultation paper MLX284. London: Medicines Control Agency, 2002.
  • 2
    Department of Health. Improving Patients' Access to Medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London: Department of Health, 2006.
  • 3
    Avery AJ, Pringle M.. Extended prescribing by UK nurses and pharmacists. Br Med J 2005; 331: 11541155.
  • 4
    Crown J.. Review of Prescribing, Supply & Administration of Medicines. Final report. London: Department of Health, 1999.
  • 5
    George J. et al. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother 2006; 40: 18431850.
  • 6
    George J. et al. Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers. Int J Pharm Pract 2007; 15: 2330.
  • 7
    Hobson RJ, Sewell GJ. Supplementary prescribing by pharmacists in England. Am J Health-Syst Pharm 2006; 63(3): 244253.
  • 8
    Hobson RJ, Sewell GJ. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci 2006; 28(2): 7690.
  • 9
    Warchal S. et al. Attitudes of successful candidates of supplementary prescribing courses to their training and their extended roles. Pharm J 2006; 276: 348352.
  • 10
    Lloyd F., Hughes C.. Pharmacists' and mentors' views on the introduction of pharmacist supplementary prescribing: a qualitative evaluation of views and context. Int J Pharm Pract 2005; 15: 3137.
  • 11
    Buckley P. et al. Inter-and intra-professional perspectives on non-medical prescribing in an NHS trust. Pharm J 2006; 277: 394398.
  • 12
    Smalley L.. Patients' experiences of pharmacist-led supplementary prescribing in primary care. Pharm J 2006; 276: 567569.
  • 13
    Ritchie J., Spencer L.. Qualitative data analysis for applied policy research. In: BrymanA., BurgessR., eds. Analysing Qualitative Data. London: Routledge, 1993.
  • 14
    Emmerton L. et al. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci 2005; 8: 217225.
  • 15
    Bonnel P., Le Nir M.. The quality of survey data: telephone versus face to face interviews. Transportation 1998; 25(2): 147167.
  • 16
    Burke LA, Miller MK. Phone interviewing as a means of data collection: Lessons learned and practical recommendations. Forum: Qual Soc Res 2001; 2(2): 18.
  • 17
    Sturges JE, Hanrahan KJ. Comparing telephone and face-to-face qualitative interviewing: a research note. Qual Res 2004; 4(1): 107.
  • 18
    Bellingham C.. Scottish contract 2006. Introducing the new Scottish contract. Pharm J 2005; 275: 637.
  • 19
    Cooper R. et al. Stakeholders' views of UK nurse and pharmacist supplementary prescribing. J Health-Serv Res Policy 2008; 13: 215221.
  • 20
    While AE, Biggs KS. Benefits and challenges of nurse prescribing. J Adv Nurs 2004; 45: 559567.
  • 21
    Bradley E., Nolan P.. Impact of nurse prescribing: a qualitative study. J Adv Nurs 2007; 59: 120128.
  • 22
    Little P. et al. Open randomised trial of prescribing strategies in managing sore throat. Br Med J 1997; 314(7082): 722727.
  • 23
    Snelgrove S., Hughes D.. Interprofessional relations between doctors and nurses: perspectives from South Wales. J Adv Nurs 2000; 31(3): 661667.
  • 24
    Grimshaw J. et al. NHS Centre for Reviews and Dissemination: getting evidence into practice. Eff Health Care 1999; 5: 116.
  • 25
    Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51(3): 390395.
  • 26
    Rogers EM. Diffusion of Innovations. New York: Free Press, 1995.